Emeishan Hongsheng Pharmaceutical Co.,Ltd In the Industrial Concentration Area, Emeishan City, Sichuan, China
Our factory covers an area of 20000 square meters,with the total investment of 20 million and the total assets of more than 60 million.
Our corporation specialized in research,manufacturing,marketing of candesartan cilexecil,Rosuvatastin calcium,Alogliptin,Linagliptin,Azilsartan,Dabigatran etexilate and related intermediates and we have obtained 13related patents.
more >
Year of Establishment:
2011
Total Assets(USD):
choose not to disclose
Total Number of Staff:
60 to 69
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Production capacity,Small Orders Accepted
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: